Gajusta, Baby Girl .
HRN: 21-34-43 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/09/2022
AMPICILLIN 250MG (VIAL)
05/09/2022
05/16/2022
IV
135mg
Q12
Neonatal Sepsis
Indication: Empiric Type of Infection: Unspecified Sepsis Compliance to guidelines: Non-compliant To Guidelines